Log In
Print this Print this

Zelboraf, vemurafenib (PLX4032, R7204, RG7204, RO5185426)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionOral small molecule inhibitor of the oncogenic BRAF V600E
Molecular Target BRAF
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today